Published in J Clin Microbiol on February 01, 2001
Epidemiology of pyrazinamide-resistant tuberculosis in the United States, 1999-2009. Clin Infect Dis (2013) 1.78
Validation of pncA gene sequencing in combination with the mycobacterial growth indicator tube method to test susceptibility of Mycobacterium tuberculosis to pyrazinamide. J Clin Microbiol (2011) 1.67
Pyrazinamide susceptibility testing in Mycobacterium tuberculosis: a systematic review with meta-analyses. Antimicrob Agents Chemother (2011) 1.62
High prevalence of childhood multi-drug resistant tuberculosis in Johannesburg, South Africa: a cross sectional study. BMC Infect Dis (2011) 1.24
Correlation between pyrazinamide activity and pncA mutations in Mycobacterium tuberculosis isolates in Taiwan. Antimicrob Agents Chemother (2003) 1.17
Does resistance to pyrazinamide accurately indicate the presence of Mycobacterium bovis? J Clin Microbiol (2005) 1.11
Widespread pyrazinamide-resistant Mycobacterium tuberculosis family in a low-incidence setting. J Clin Microbiol (2003) 1.06
Comparison of the ESP and BACTEC systems for testing susceptibilities of Mycobacterium tuberculosis complex isolates to pyrazinamide. J Clin Microbiol (2002) 1.01
A Global Perspective on Pyrazinamide Resistance: Systematic Review and Meta-Analysis. PLoS One (2015) 0.99
Temperature-mediated heteroduplex analysis for detection of pncA mutations associated with pyrazinamide resistance and differentiation between Mycobacterium tuberculosis and Mycobacterium bovis by denaturing high- performance liquid chromatography. J Clin Microbiol (2004) 0.97
Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis in Brazil. Antimicrob Agents Chemother (2005) 0.96
Detection by denaturing gradient gel electrophoresis of pncA mutations associated with pyrazinamide resistance in Mycobacterium tuberculosis isolates from the United States-Mexico border region. Antimicrob Agents Chemother (2005) 0.94
Systematic review of mutations in pyrazinamidase associated with pyrazinamide resistance in Mycobacterium tuberculosis clinical isolates. Antimicrob Agents Chemother (2015) 0.94
Pyrazinamide susceptibility testing of Mycobacterium tuberculosis by high resolution melt analysis. Tuberculosis (Edinb) (2013) 0.91
Outbreak of pyrazinamide-monoresistant tuberculosis identified using genotype cluster and social media analysis. Int J Tuberc Lung Dis (2014) 0.78
Role of pyrazinamide in the emergence of extensively drug-resistant tuberculosis: a multi-strain mathematical model. Antimicrob Agents Chemother (2016) 0.75
Comparison and development of pyrazinamide susceptibility testing methods for tuberculosis in Thailand. Diagn Microbiol Infect Dis (2015) 0.75
Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol (1993) 45.22
Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA (1999) 27.82
Evaluation of the BACTEC radiometric method for recovery of mycobacteria and drug susceptibility testing of Mycobacterium tuberculosis from acid-fast smear-positive specimens. J Clin Microbiol (1983) 10.49
Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus. Nat Med (1996) 8.94
Identification of major slowly growing pathogenic mycobacteria and Mycobacterium gordonae by high-performance liquid chromatography of their mycolic acids. J Clin Microbiol (1988) 6.42
Zoonotic tuberculosis due to Mycobacterium bovis in developing countries. Emerg Infect Dis (1998) 5.51
Pyrazinamide susceptibility and amidase activity of tubercle bacilli. Am Rev Respir Dis (1967) 5.45
The epidemiology of tuberculosis among foreign-born persons in the United States, 1986 to 1993. N Engl J Med (1995) 5.34
The epidemiology of Mycobacterium bovis infections in animals and man: a review. Tuber Lung Dis (1995) 5.20
Rapid and sensitive detection of Mycobacterium leprae using a nested-primer gene amplification assay. J Clin Microbiol (1990) 4.04
Use of various genetic markers in differentiation of Mycobacterium bovis strains from animals and humans and for studying epidemiology of bovine tuberculosis. J Clin Microbiol (1994) 3.96
Identification of a polymorphic nucleotide in oxyR specific for Mycobacterium bovis. J Clin Microbiol (1996) 3.70
Differentiation among members of the Mycobacterium tuberculosis complex by molecular and biochemical features: evidence for two pyrazinamide-susceptible subtypes of M. bovis. J Clin Microbiol (2000) 2.64
Mycobacterium bovis infections in San Diego: a clinicoepidemiologic study of 73 patients and a historical review of a forgotten pathogen. Medicine (Baltimore) (1993) 2.59
The zoonotic importance of Mycobacterium bovis. Tuber Lung Dis (1996) 2.50
Rapid differentiation of bovine and human tubercle bacilli based on a characteristic mutation in the bovine pyrazinamidase gene. J Clin Microbiol (1997) 2.18
Phenotypic characterization of pncA mutants of Mycobacterium tuberculosis. Antimicrob Agents Chemother (2000) 2.15
pncA mutations as a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis: spread of a monoresistant strain in Quebec, Canada. Antimicrob Agents Chemother (2000) 2.10
Restriction fragment length polymorphism analysis of Mycobacterium tuberculosis isolated from countries in the western pacific region. J Clin Microbiol (2000) 2.05
Drug-resistant tuberculosis: inconsistent results of pyrazinamide susceptibility testing. JAMA (1995) 1.83
Allele-specific PCR method based on pncA and oxyR sequences for distinguishing Mycobacterium bovis from Mycobacterium tuberculosis: intraspecific M. bovis pncA sequence polymorphism. J Clin Microbiol (1998) 1.66
Comparison of phenotypic and genotypic methods for pyrazinamide susceptibility testing with Mycobacterium tuberculosis. J Clin Microbiol (2000) 1.51
Aerial dissemination of pulmonary tuberculosis. Am Rev Tuberc (1957) 1.19
Controlled clinical trial of four short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis. Second report. Lancet (1973) 0.96
The trouble with bovine tuberculosis. Bull Hist Med (1985) 0.94
Controlled clinical trial of four short-course regimens of chemotherapy for two durations in the treatment of pulmonary tuberculosis: first report: Third East African/British Medical Research Councils study. Am Rev Respir Dis (1978) 0.92
Tuberculosis due to Mycobacterium bovis in the Australian population: DNA typing of isolates, 1970-1994. Int J Tuberc Lung Dis (1999) 0.91
Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol (1993) 45.22
An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med (1992) 18.11
IS6110, an IS-like element of Mycobacterium tuberculosis complex. Nucleic Acids Res (1990) 16.68
Repetitive DNA sequences as probes for Mycobacterium tuberculosis. J Clin Microbiol (1988) 14.26
Polymerase chain reaction amplification of a repetitive DNA sequence specific for Mycobacterium tuberculosis. J Infect Dis (1990) 13.18
The resurgence of tuberculosis: is your laboratory ready? J Clin Microbiol (1993) 11.70
IS6110: conservation of sequence in the Mycobacterium tuberculosis complex and its utilization in DNA fingerprinting. Mol Cell Probes (1991) 10.70
Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family. JAMA (1996) 9.45
Chromosomal DNA fingerprint patterns produced with IS6110 as strain-specific markers for epidemiologic study of tuberculosis. J Clin Microbiol (1991) 8.24
Detection of Mycobacterium tuberculosis in sputum samples using a polymerase chain reaction. Am Rev Respir Dis (1991) 7.94
Hospital outbreak of multidrug-resistant Mycobacterium tuberculosis infections. Factors in transmission to staff and HIV-infected patients. JAMA (1992) 7.84
Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis. A risk to patients and health care workers. Ann Intern Med (1992) 7.50
Characterization of rifampin-resistance in pathogenic mycobacteria. Antimicrob Agents Chemother (1994) 5.64
A multi-institutional outbreak of highly drug-resistant tuberculosis: epidemiology and clinical outcomes. JAMA (1996) 4.38
Genetic relatedness among strains of the Mycobacterium tuberculosis complex. Analysis of restriction fragment heterogeneity using cloned DNA probes. Am Rev Respir Dis (1986) 4.13
Multiplex PCR assay specific for the multidrug-resistant strain W of Mycobacterium tuberculosis. J Clin Microbiol (1994) 3.85
Spacer oligonucleotide typing of bacteria of the Mycobacterium tuberculosis complex: recommendations for standardised nomenclature. Int J Tuberc Lung Dis (2001) 3.82
The rpoB gene of Mycobacterium tuberculosis. Antimicrob Agents Chemother (1994) 3.78
DNA large restriction fragment patterns of sporadic and epidemic nosocomial strains of Mycobacterium chelonae and Mycobacterium abscessus. J Clin Microbiol (1993) 3.65
Stability of DNA fingerprint pattern produced with IS6110 in strains of Mycobacterium tuberculosis. J Clin Microbiol (1994) 3.35
Mixed-linker polymerase chain reaction: a new method for rapid fingerprinting of isolates of the Mycobacterium tuberculosis complex. J Clin Microbiol (1993) 3.20
Rapid, amplification-based fingerprinting of Mycobacterium tuberculosis. J Gen Microbiol (1993) 3.19
Transmission of multidrug-resistant Mycobacterium tuberculosis among persons with human immunodeficiency virus infection in an urban hospital: epidemiologic and restriction fragment length polymorphism analysis. J Infect Dis (1993) 3.16
DNA polymorphisms in strains of Mycobacterium tuberculosis analyzed by pulsed-field gel electrophoresis: a tool for epidemiology. J Clin Microbiol (1992) 2.89
Evaluation of a line probe assay kit for characterization of rpoB mutations in rifampin-resistant Mycobacterium tuberculosis isolates from New York City. J Clin Microbiol (1997) 2.81
A rapid method for screening antimicrobial agents for activities against a strain of Mycobacterium tuberculosis expressing firefly luciferase. Antimicrob Agents Chemother (1993) 2.39
Isolation of plasmids from mycobacteria. Infect Immun (1979) 2.30
Turnaround times for mycobacterial cultures. J Clin Microbiol (1997) 2.30
Outbreak of multi-drug-resistant tuberculosis in a New York State prison, 1991. Am J Epidemiol (1994) 2.20
Phenotypic characterization of pncA mutants of Mycobacterium tuberculosis. Antimicrob Agents Chemother (2000) 2.15
Characterization of an SAV organism and proposal of Mycobacterium triplex sp. nov. J Clin Microbiol (1996) 2.09
Large restriction fragment patterns of genomic Mycobacterium fortuitum DNA as strain-specific markers and their use in epidemiologic investigation of four nosocomial outbreaks. J Clin Microbiol (1992) 2.07
The molecular epidemiology of tuberculosis in New York City: the importance of nosocomial transmission and laboratory error. Tuber Lung Dis (1996) 2.06
DNA fingerprinting by infrequent-restriction-site amplification. J Clin Microbiol (1996) 2.01
Initial clarithromycin monotherapy for Mycobacterium avium-intracellulare complex lung disease. Am J Respir Crit Care Med (1994) 1.97
Characterization of streptomycin resistance mechanisms among Mycobacterium tuberculosis isolates from patients in New York City. Antimicrob Agents Chemother (1996) 1.92
Simultaneous infection with multiple strains of Mycobacterium tuberculosis. Clin Infect Dis (2001) 1.90
Differentiation of Mycobacterium tuberculosis and Mycobacterium bovis BCG by a polymerase chain reaction assay. Mol Cell Probes (1991) 1.77
Transmission of Mycobacterium tuberculosis from medical waste. JAMA (2000) 1.67
Nosocomial outbreak of tuberculosis in a renal transplant unit: application of a new technique for restriction fragment length polymorphism analysis of Mycobacterium tuberculosis isolates. J Infect Dis (1993) 1.53
Characterization of spontaneous, In vitro-selected, rifampin-resistant mutants of Mycobacterium tuberculosis strain H37Rv. Antimicrob Agents Chemother (2000) 1.52
Pathogenicity of Mycobacterium avium for human monocytes: absence of macrophage-activating factor activity of gamma interferon. Infect Immun (1989) 1.52
A new agent of mycobacterial lymphadenitis in children: Mycobacterium heidelbergense sp. nov. J Clin Microbiol (1997) 1.52
DNA fingerprinting of pathogenic bacteria by fluorophore-enhanced repetitive sequence-based polymerase chain reaction. Arch Pathol Lab Med (1995) 1.34
False-positive cultures of Mycobacterium tuberculosis. Chest (1984) 1.32
Expression of contact-dependent cytolytic activity by Mycobacterium tuberculosis and isolation of the genomic locus that encodes the activity. Infect Immun (1993) 1.31
A continuing survey of drug-resistant tuberculosis, New York City, April 1994. Arch Intern Med (1997) 1.31
Isolation and sequencing of the replication region of Mycobacterium avium plasmid pLR7. J Bacteriol (1995) 1.29
Analysis of plasmids in Mycobacterium avium-intracellulare isolates from persons with acquired immunodeficiency syndrome. Am Rev Respir Dis (1986) 1.25
Nosocomial transmission of Mycobacterium tuberculosis: role of health care workers in outbreak propagation. J Infect Dis (1995) 1.24
Evidence for plasmid-mediated restriction-modification in Mycobacterium avium intracellulare. J Gen Microbiol (1981) 1.19
Identification of Mycobacterium species by PCR-restriction fragment length polymorphism analyses using fluorescence capillary electrophoresis. J Clin Microbiol (1999) 1.19
Strain classification of Mycobacterium tuberculosis: congruence between large sequence polymorphisms and spoligotypes. Int J Tuberc Lung Dis (2011) 1.17
Bioluminescence method to evaluate antimicrobial agents against Mycobacterium avium. Antimicrob Agents Chemother (1995) 1.16
Characterization of plasmids from strains of Mycobacterium avium-intracellulare. Rev Infect Dis (1982) 1.15
IS1549 from Mycobacterium smegmatis forms long direct repeats upon insertion. J Bacteriol (1998) 1.13
Automated DNA fingerprinting analysis of Mycobacterium tuberculosis using fluorescent detection of PCR products. J Clin Microbiol (1996) 1.12
Mycobacterium kubicae sp. nov., a slowly growing, scotochromogenic Mycobacterium. Int J Syst Evol Microbiol (2000) 1.11
Association of plasmids and virulence of Mycobacterium avium complex. Am Rev Respir Dis (1988) 1.09
Flow cytometric testing of susceptibilities of Mycobacterium tuberculosis isolates to ethambutol, isoniazid, and rifampin in 24 hours. J Clin Microbiol (1998) 1.09
Correlation of proteolytic activity of Pseudomonas aeruginosa with site of isolation. J Clin Microbiol (1980) 1.04
Access to newer laboratory procedures: a call for action. Int J Tuberc Lung Dis (2000) 1.03
The function of tail fibers in triggering baseplate expansion of bacteriophage T4. J Mol Biol (1980) 1.02
Predictors of discordant tuberculin skin test and QuantiFERON®-TB Gold In-Tube results in various high-risk groups. Int J Tuberc Lung Dis (2011) 0.98
Tuberculosis outbreak in a Texas prison, 1994. Epidemiol Infect (1996) 0.97
Tuberculosis outbreak among healthcare workers in a community hospital. Am J Respir Crit Care Med (1995) 0.95
Restriction endonuclease mapping and cloning of Mycobacterium intracellulare plasmid pLR7. Gene (1984) 0.94
Aminopeptidases of Bacillus subtilis. J Bacteriol (1975) 0.93
Genetic differences between BCG substrains. Tuber Lung Dis (1995) 0.92
Tuberculosis in health care workers at a hospital with an outbreak of multidrug-resistant Mycobacterium tuberculosis. Arch Intern Med (1995) 0.91
Evaluation of infection control measures in preventing the nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis in a New York City hospital. Infect Control Hosp Epidemiol (1995) 0.91
Comparative studies and laboratory diagnosis of Vibrio vulnificus, an invasive Vibrio sp. J Clin Microbiol (1984) 0.91
Safe determination of susceptibility of Mycobacterium tuberculosis to antimycobacterial agents by flow cytometry. J Clin Microbiol (1999) 0.90
Reverse dot blot assay (insertion site typing) for precise detection of sites of IS6110 insertion in the Mycobacterium tuberculosis genome. J Clin Microbiol (2001) 0.89
Characterization of IS6110 restriction fragment length polymorphism patterns and mechanisms of antimicrobial resistance for multidrug-resistant isolates of Mycobacterium tuberculosis from a major reference hospital in Assiut, Egypt. J Clin Microbiol (2001) 0.88
The effect of baseplate mutations on the requirement for tail-fiber binding for irreversible adsorption of bacteriophage T4. J Mol Biol (1977) 0.88
Apoptosis induced by cold shock in vitro is dependent on cell growth phase. Biochem Biophys Res Commun (1987) 0.85
Phage typing of the Mycobacterium avium-intracellulare-scrofulaceum complex. Am Rev Respir Dis (1981) 0.84
Phage typing of the Mycobacterium avium-intracellulare-scrofulaceum complex. A study of strains of diverse geographic and host origin. Am Rev Respir Dis (1985) 0.84
Detection of the 10-kD antigen structural gene in mycobacteria by using the polymerase chain reaction. Diagn Microbiol Infect Dis (1994) 0.81
Clonal relationships in a shelter-associated outbreak of drug-resistant tuberculosis: 1983-1997. Int J Tuberc Lung Dis (2002) 0.80
IS6110 homologs are present in multiple copies in mycobacteria other than tuberculosis-causing mycobacteria. J Clin Microbiol (1998) 0.79
Molecular epidemiology and tuberculosis control. JAMA (2000) 0.77
Genetic similarity among Mycobacterium avium isolates from blood, stool, and sputum of persons with AIDS. J Infect Dis (1997) 0.77
Detection of Mycobacterium tuberculosis infection by whole-blood interferon-gamma release assay. Clin Infect Dis (2003) 0.75
Positive Weil-Felix reactions in a case of rickettsialpox. Int J Dermatol (1989) 0.75
Immunoperoxidase staining for detection of Colorado tick fever virus, and a study of congenital infection in the mouse. Am J Trop Med Hyg (1979) 0.75
Pneumonia in chronic obstructive lung disease. Infect Dis Clin North Am (1991) 0.75
Inhibition of Bacillus subtilis aminopeptidase D by beta-lactam antibiotics. Biochim Biophys Acta (1980) 0.75